137 related articles for article (PubMed ID: 3217918)
1. Conditions affecting the responses of human platelets to epinephrine.
Lalau Keraly C; Kinlough-Rathbone RL; Packham MA; Suzuki H; Mustard JF
Thromb Haemost; 1988 Oct; 60(2):209-16. PubMed ID: 3217918
[TBL] [Abstract][Full Text] [Related]
2. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
Greco NJ; Tenner TE; Tandon NN; Jamieson GA
Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
[TBL] [Abstract][Full Text] [Related]
3. Epinephrine potentiates human platelet activation but is not an aggregating agent.
Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
[TBL] [Abstract][Full Text] [Related]
4. Adrenaline-induced reactions of human platelets in hirudin plasma.
Glusa E; Markwardt F
Haemostasis; 1980; 9(3):188-92. PubMed ID: 7372203
[TBL] [Abstract][Full Text] [Related]
5. Factors responsible for ADP-induced release reaction of human platelets.
Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
[TBL] [Abstract][Full Text] [Related]
6. Agglutination of rabbit platelets in plasma by the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
Packham MA; Bryant NL; Guccione MA
Thromb Haemost; 1990 Apr; 63(2):282-5. PubMed ID: 2363129
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
Packham MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
[TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
Glusa E
Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
[TBL] [Abstract][Full Text] [Related]
9. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
[TBL] [Abstract][Full Text] [Related]
10. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
Lages B; Weiss HJ
Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
[TBL] [Abstract][Full Text] [Related]
11. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
13. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
Oliver JA; Albrecht RM
Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
[TBL] [Abstract][Full Text] [Related]
14. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl).
Rand ML; Neiman J; Jakowec DM; Packham MA
Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118
[TBL] [Abstract][Full Text] [Related]
15. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
Milton JG; Frojmovic MM
J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
[TBL] [Abstract][Full Text] [Related]
16. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
Steen VM; Holmsen H
Thromb Haemost; 1985 Oct; 54(3):680-3. PubMed ID: 4089798
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
Shattil SJ; Budzynski A; Scrutton MC
Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility and temporal stability of ADP-induced platelet aggregation: comparison of the anticoagulants sodium citrate and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone.
Horne WC; Anderson GM; Cohen DJ
Am J Hematol; 1991 Sep; 38(1):48-53. PubMed ID: 1897514
[TBL] [Abstract][Full Text] [Related]
20. Properties of washed human platelets.
Kinlough-Rathbone RL; Mustard JF; Packham MA; Perry DW; Reimers HJ; Cazenave JP
Thromb Haemost; 1977 Apr; 37(2):291-308. PubMed ID: 327607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
